Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Accolade, Inc. - common stock (NQ:ACCD)

7.005 -0.005 (-0.07%)
Streaming Delayed Price Updated: 11:45 AM EDT, Mar 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Accolade, Inc. - common stock

< Previous 1 2 3 4 5 6 7 Next >
Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday
Ark Invest made notable trades on Feb. 28, 2025. They purchased shares in ACHR, RXRX, TEM, and IRDM, while selling shares in TWST, ADYEY, ACCD, and EXAS. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday
Ark Invest made significant trades on Friday, including buying Amazon and Roblox stock and selling Palantir stock. Other key trades were also made. 
Via Benzinga
Cathie Wood's Ark Invest Bets On Biotech With CRISPR Therapeutics Investment, Exits Roblox
Cathie Wood-led Ark Invest made significant trades involving CRSP, TXG, RBLX, ACHR, NU, ADYEY, ACCD, and AVAV. 
Via Benzinga
Accolade Q3 Earnings Assessment
Via Benzinga
Earnings Scheduled For January 9, 2025
Via Benzinga
What's Going On With Accolade Stock Wednesday?
Accolade shares are trading higher on Wednesday after it announced that Transcarent will acquire the company. 
Via Benzinga
Breaking Down Accolade: 8 Analysts Share Their Views
Via Benzinga
Cathie Wood's Wednesday Moves: Ark Invest Dumps Robinhood Stock
On Wednesday January 22, 2025, Cathie Wood-led Ark Invest sold $927,107 worth of Robinhood shares. 
Via Benzinga
Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies
Cathie Wood-led Ark Invest made significant trades involving ACCD, DE, NTLA, PATH, CCJ, OKLO, ILMN, ESLT, and ABSI. 
Via Benzinga
Topics Government
Exposures Political
Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidia
Ark Invest made significant trades involving Tempus AI, CRISPR Therapeutics, UiPath, Roblox, Reddit, Accolade, and Ibotta. ARKG and ARKK funds bought shares, while ARKW and ARKF funds sold shares. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Forecasting The Future: 6 Analyst Projections For Accolade
Via Benzinga
Uncovering Potential: Accolade's Earnings Preview
Via Benzinga
Top Wall Street Forecasters Revamp Accolade Price Expectations Ahead Of Q2 Earnings
Via Benzinga
Why Is Accolade Stock Trading Over 100% On Tuesday?
Transcarent to acquire Accolade Inc. for $7.03 per share, combining AI-driven care solutions with personalized healthcare expertise. Deal closes Q2 2025. 
Via Benzinga
Accolade's Q2 Boost: Revenue Rises, Losses Shrink, And Profitability Looms
Accolade stock up after beating Q2 2025 revenue and EPS estimates, expecting full year Adjusted EBITDA profitability and positive cash flow. 
Via Benzinga
Dow Dips Around 400 Points As Treasury Yields Top 4%: Investor Optimism Declines, But Fear Index Remains In 'Greed' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
PepsiCo, MEDIROM Healthcare Technologies And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Apple To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Nike, Accolade And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are a hot topic on Friday and we're breaking down all of the latest news sending shares higher and lower! 
Via InvestorPlace
ACCD Stock Earnings: Accolade Beats EPS, Beats Revenue for Q1 2025
ACCD stock results show that Accolade beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2025. 
Via InvestorPlace
Accolade Stock Tumbles On Q1 Earnings, Weak Guidance: What You Need To Know
Accolade Inc shares are tanking in Thursday's after-hours session after the company reported financial results for its fiscal first quarter and issued weak guidance. 
Via Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The popular growth investor bought into one of Thursday's biggest losers and two stocks that have fallen sharply over the past year. 
Via The Motley Fool
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
ACCD Stock Earnings: Accolade Misses EPS, Beats Revenue for Q4 2024
ACCD stock results show that Accolade missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Alphabet To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.